Biogen Inc. buy Guggenheim
Start price
30.04.26
/
50%
€164.34
Target price
30.04.27
€222.82
Performance (%)
-1.84%
Price
30.04.26
€161.32
Summary
This prediction is currently active. With a performance of -1.84%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 30.04.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -1.84% |
| iShares Core DAX® | 0.985% |
| iShares Nasdaq 100 | 2.067% |
| iShares Nikkei 225® | 2.270% |
| iShares S&P 500 | 1.043% |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its "buy" rating reaffirmed by Guggenheim. They now have a $260.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat